NASDAQ:HSKA - Nasdaq - US42805E3062 - Common Stock - Currency: USD
119.99
+0.05 (+0.04%)
The current stock price of HSKA is 119.99 USD. In the past month the price increased by 2.45%. In the past year, price increased by 42.46%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
SYK | STRYKER CORP | 31.4 | 145.92B | ||
MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
DXCM | DEXCOM INC | 53.81 | 34.68B | ||
RMD | RESMED INC | 26.21 | 34.03B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. The company is headquartered in Loveland, Colorado and currently employs 808 full-time employees. The Company’s portfolio includes point-of-care (POC) diagnostic laboratory instruments and consumables, POC digital imaging diagnostic products, local and cloud-based data services, practice information management software (PIMS) and related software and support, reference laboratory testing, allergy testing and immunotherapy, heartworm preventive products, and vaccines. The firm has two segments. The North America segment consists of the United States, Canada and Mexico. The segment also includes the contract manufacturing of vaccines and pharmaceutical products and a small veterinary laboratory. The International segment consists of geographies outside of North America, primarily its operations in Germany, Italy, Spain, France, Switzerland, Australia and Malaysia. The segment includes its PIMS business and veterinary laboratories.
Heska Corporation
3760 Rocky Mountain Ave
Loveland COLORADO 80538 US
CEO: Kevin S. Wilson
Employees: 808
Company Website: https://www.heska.com/
Phone: 19704937272.0
The current stock price of HSKA is 119.99 USD. The price increased by 0.04% in the last trading session.
The exchange symbol of Heska Corporation is HSKA and it is listed on the Nasdaq exchange.
HSKA stock is listed on the Nasdaq exchange.
10 analysts have analysed HSKA and the average price target is 132.6 USD. This implies a price increase of 10.51% is expected in the next year compared to the current price of 119.99. Check the Heska Corporation stock analysts ratings, price target forecast and up-and down grades for more detailed information.
Heska Corporation (HSKA) has a market capitalization of 1.31B USD. This makes HSKA a Small Cap stock.
Heska Corporation (HSKA) currently has 808 employees.
Heska Corporation (HSKA) has a support level at 119.86 and a resistance level at 120. Check the full technical report for a detailed analysis of HSKA support and resistance levels.
The Revenue of Heska Corporation (HSKA) is expected to grow by 9.92% in the next year. Check the estimates tab for more information on the HSKA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
HSKA does not pay a dividend.
Heska Corporation (HSKA) will report earnings on 2023-08-07, before the market open.
Heska Corporation (HSKA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.93).
ChartMill assigns a technical rating of 9 / 10 to HSKA. When comparing the yearly performance of all stocks, HSKA is one of the better performing stocks in the market, outperforming 93.8% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to HSKA. HSKA has a great financial health rating, but its profitability evaluates not so good.
Over the last trailing twelve months HSKA reported a non-GAAP Earnings per Share(EPS) of -1.93. The EPS decreased by -51.97% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | 0.23 |
ChartMill assigns a Buy % Consensus number of 78% to HSKA. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of 55.25% and a revenue growth 9.92% for HSKA